Laboratory Diagnosis of Inherited Metabolic Diseases. Edition No. 2

Authors

Uttam Garg Garg Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO, United States; University of Missouri School of Medicine, Kansas City, MO, USA. Dr. Uttam Garg has published over 150 research papers, review articles, and book chapters in the area of clinical biochemistry, therapeutic drug monitoring and toxicology, and Co-Edited a book on Clinical Applications of Mass Spectrometry. His research interests include methods development in clinical laboratory diagnosis. His research interests include clinical method development on a variety of diagnostic platforms including mass spectrometry. He received his Ph.D. in Experimental Medicine from the Postgraduate Institute of Medical Education and Research in India. He received his postdoctoral training in Pharmacology at and Clinical Chemistry at New York Medical College and University of Minnesota Medical School respectively. Before joining his current position, he served as faculty at the NYU Medical Center and the University of Minnesota Medical School. Bryce Heese Director of the Division of Clinical Genetics at Children's Mercy Hospital, and Assoicate Professor of Pediatrics, University of Missouri School of Medicine in Kansas City, USA. Bryce Heese MD is the Director of the Division of Clinical Genetics at Children's Mercy Hospital, and Assoicate Professor of Pediatrics at the University of Missouri School of Medicine in Kansas City. He has had experience with national and regional workgroups dealing with newborn screening process and he has served as a medical consultant and advisory committee member for several state screening programs. Jennifer Gannon Children's Mercy Hospital, USA. Jennifer Gannon, MD, is a clinical biochemical geneticist in the Division of Clinical Genetics at Children's Mercy Hospital, and Associate Professor of Pediatrics at the University of Missouri School of Medicine in Kansas City. She serves as a medical consultant for regional newborn screening programs, including advising in the development of referral protocols for newborn screening tests in her role as member and chair of advisory committees. Her clinical practice includes evaluation of infants with abnormal newborn screening test results and treatment of patients with inborn errors of metabolism.